期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

KAI1基因与妇科肿瘤 被引量：1

下载PDF
导出
摘要 KAI1基因是定位于人染色体11p11.2的转移抑制基因,主要参与调节细胞间的粘附,通过封闭肿瘤细胞表面的粘附受体,使肿瘤细胞不易脱离原发灶而抑制转移。KAI1蛋白已被证实对多种肿瘤的转移有抑制作用。本文对KAI1基因的结构、功能及其与妇科肿瘤的关系作一综述。
作者 蒋静 唐良萏 阳志宁
机构地区 重庆医科大学附属第一医院 川北医学院附属医院
出处 《四川医学》 CAS 2006年第6期571-573,共3页 Sichuan Medical Journal
关键词 KAI1基因 转移抑制基因 妇科肿瘤
分类号 R737.3 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献49

  • 1Gaarenstroom KN, Bonfrer JM, Korse CM, et al. Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer [J]. Anticancer Res, 1997, 17(4B): 2955-2958.
  • 2Trattner M, Graf AH, Lax S, et al. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume [J]. Gynecol Oncol, 2001, 82(1): 11-16.
  • 3Jackson P, Millar D, Kingsley E, et al. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in ivasive cancers or cancer cell lines [J]. Cancer Lett, 2000, 157(2): 169-176.
  • 4Mashimo T, Watabe M, Hirota S, et al. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53 [J]. Proc Natl Acad Sci USA, 1998, 95 (19):11307-11311.
  • 5Duriez C, Falette N, Cortes U, el al. Absence of p53-dependent induction of the metastasis suppressor KAI1 gene after DNA damage [J]. Oncogene, 2000. 19(20):2461-2464.
  • 6Nguyen HN, Averette HE. Biolog3, of cervical careinoma [R]. Semin Surg Oncol, 1999, 16(3): 212-216.
  • 7Morice P, Castaigne D, Pautier P, et al. Interesl of pelvic and paraaortic lymphadenectomy in patienls wilh slage Ⅰ B and Ⅱ cervical carcinoma [J]. Gynecol Oncot. 1999, 73(1): 106-110.
  • 8Kristensen GB, Abeler VM, Risberg B, et al. Tumor size. depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma [J]. Gynecol Oncol, 1999. 74(2): 245-251.
  • 9Lai CH, Hong JH, Hsueh S, et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or Ⅱ cervical careinoma patients with or without pelvic lymph node metastases: and analysis of 891 cases [J]. Cancer, 1999,85(7) : 1537-1546.
  • 10Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 [J]. Science, 1995, 268 (5212):884-886.

共引文献20

同被引文献7

  • 1严泽军,杨为民,杨木兰,章慧平.能动性相关蛋白-1和缺氧诱导因子-1α在膀胱移行细胞癌中的表达及临床意义[J].临床外科杂志,2006,14(2):105-107. 被引量：1
  • 2李成刚,黄志强,王燕生.胆管癌与胰腺导管癌的比较性研究[J].消化外科,2006,5(2):147-149. 被引量：2
  • 3Furuya M, Kato H, Nishimura N, et al. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination:morphologic alteration and reduced expression of betal integrin subsets[J]. Cancer Res, 2005,65 (7) : 2617-2625.
  • 4Funakoshi T,Tachibana I,Hoshida Y,et al.Expression of tetraspanins in human lung cancer cell:frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer [J]. Oncogene, 2003,22( 5 ) :674-687.
  • 5Nishida M, Miyagawa JI, Yamashita S,et al. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor,in human atherosclerotic plaques:possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation[J]. Arterioacler Thromb Vasc Biol, 2000,20 ( 5 ): 1236- 1243.
  • 6Takemura T, Hino S, Murata Y, et al. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF)to preserve renal epithelial cell viability[J]. Kidney Int, 1999,55( 1 ) :71-81.
  • 7Furuya M,Kato H,Nishimum N,et al. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal disseminalion: morphologic alteration and reduced expression of beta1 integrin subsets[J]. Cancer Res,2005,65(7):2617-2625.

引证文献1

二级引证文献2

四川医学
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部